Which peptides had FDA approval withdrawn or were discontinued?

Short answer

FDA withdrew the approval of three substances profiled here (Nesiritide, Peginesatide and Sermorelin), and Drugs@FDA lists every product of four more as discontinued (Albiglutide, Dasiglucagon, Enfuvirtide and Gonadorelin).

Each entry below quotes its profile and links to the full answer there.

Approval withdrawn 3

FDA-approved, but discontinued 4

PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.

Citations

Sources

Coverage and sources →

Numbered markers in the text point here. Each link opens the original public record.

  1. 1
    Janssen Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 16 New Drug Applications (May 14, 2020) · FR Doc. 2020-10367 ↗

    Federal Register · Official source · Source checked November 15, 2026

  2. 2
    Drugs@FDA: NATRECOR (nesiritide), NDA 020920 · original approval August 10, 2001 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  3. 3
    Takeda Pharmaceuticals U.S.A., Inc.; Withdrawal of Approval of a New Drug Application for OMONTYS (peginesatide) Injection (February 13, 2019) · FR Doc. 2019-02146 ↗

    Federal Register · Official source · Source checked November 16, 2026

  4. 4
    Drugs@FDA: OMONTYS (peginesatide acetate), NDA 202799 · original approval March 27, 2012 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  5. 5
    Determination That GEREF (Sermorelin Acetate) Injection Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness (March 4, 2013) · FR Doc. 2013-04827 ↗

    Federal Register · Official source · Source checked November 15, 2026

  6. 6
    Drugs@FDA: GEREF (sermorelin acetate), NDA 020443 · original approval September 26, 1997 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  7. 7
    Drugs@FDA: TANZEUM (albiglutide), application 125431 · original approval April 15, 2014 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  8. 8
    Drugs@FDA: ZEGALOGUE (dasiglucagon hydrochloride), NDA 214231 · original approval March 22, 2021 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  9. 9
    ZEGALOGUE (dasiglucagon) injection · SPL version 3 · published 2026-06-17 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  10. 10
    Drugs@FDA: FUZEON (enfuvirtide), NDA 021481 · original approval March 13, 2003 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  11. 11
    Drugs@FDA: FACTREL (gonadorelin hydrochloride), NDA 018123 · original approval September 30, 1982 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  12. 12
    Drugs@FDA: LUTREPULSE KIT (gonadorelin acetate), NDA 019687 · original approval October 10, 1989 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026